Why is IFF down?
Down 12% from Nov 2 to Nov 10.
- Its results release on Nov 3 reported quarterly revenue of $1.94B.
Down 12% from Nov 2 to Nov 10.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Since its Nov 2021 high | Down 45% |
| Latest filing | 8-K, Nov 3 |
Fri Dec 18: Ex-dividend, $0.40 a shareAt the open. Pays Jan 13.
After its last 4 reports it closed +6.8% on average, higher 3 of 4 times.
Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means
IFF is #4 of 14 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 4 |
Free cash flow over four quarters: IFF $501M, SXT -$17.5M.
Expected to report Wed Feb 10, after the close (in 92 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $1.9B, 4% more than a year ago.
“On a comparable basis 3 , currency neutral adjusted operating EBITDA 2 improved 6% versus the prior-year period, driven by volume growth.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Scent | $689M | $665M | $652M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 3)
| Measure | Figure |
|---|---|
| Sales | $7.5B to $7.6B |
“At the same time, we expect fourth-quarter profitability to be softer, particularly in Health & Biosciences, reflecting higher costs as well as reinvestments to strengthen the business.”
From its results filing (SEC filing · Nov 3)
Sales fell 4.3% a year over 3 years, fiscal 2022 to 2025.
Pays $1.60 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 3, 2026 | -6.2% | -4.9% | -9.8% |
| Aug 4, 2026 | +3.6% | +8.9% | +5.1% |
| May 5, 2026 | +14.2% | +17.2% | +10.9% |
Sales grew in two of the last four years, to $11B in 2025. It lost money in 2025 after a profit in 2024.
RSI 37.2, MACD below signal, below its 50-day, above its 200-day. Not scored.
Its dividends come to 80% of its free cash flow.
| Dividend | $1.60 a share a year |
| Paid out | About $401M a year |
| Free cash flow | $501M |
One insider bought $20.3M across 2 filings, and 3 insiders sold $1.3M across 3 filings, in the last 6 months. The newest:
4 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: IFF is under 0.1% of VYM, under 0.1% of IVV, and under 0.1% of SPY, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026 (SPY's as filed by IVV).
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate 30% to 35% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates a little over 35% of profits, is a global leader in probiotics and enzymes.
“The market for our products is highly competitive.”
IFF scores 8 today, which Breakaway calls Average. It is #4 of 14 in Industrial Organic Chemicals by Quality Score, with 2 of 14 chart checks firing. Down 12% from Nov 2 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
IFF scores 8 today, which Breakaway calls Average (6 to 10). That is #4 of 14 in Industrial Organic Chemicals by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind IFF's 8.
One insider bought $20.3M across 2 filings, and 3 insiders sold $1.3M across 3 filings, in the last 6 months. The newest is de Mendonca Ana Paula Teles, President, Scent, who sold $476K on Aug 17. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.